Author

Colleen Lawton

Observed name: Colleen A. Lawton

Institution: Medical College of Wisconsin

Observed institution: Medical College of Wisconsin

OpenAlex ID: A5113638666

Predicting survival and the role of androgen suppressive therapy (AST): Radiation therapy oncology group (RTOG) phase III randomized prostate cancer trials

1998 · Mack Roach, Jiandong Lu, et al. · International Journal of Radiation Oncology*Biology*Physics · 6

Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology

2026 · Sophia C. Kamran, Monica Borges, et al. · JCO Precision Oncology

Adjuvant androgenic blockade after teleradiotherapy for prostate cancer: long-term results of phase III rtog 85-31 study

2020 · Miljenko V. Pilepich, Kathryn Winter, et al. · Oncourology (Russian Society of Oncourologists)

P124 Subjective pathology tumor grading: Impact on design and analysis of radiation therapy oncology group (RTOG) prostate trial 8531

1997 · Kathryn Winter, David Grignon, et al. · Controlled Clinical Trials

RTOG'S first quality of life study - RTOG 90-20 - a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer

1994 · Deborah Watkins-Bruner, Charles Scott, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 5

Citation count: 6

H-index: 1

I10-index: